13D/13G Filings - EFFECTOR THERAPEUTICS INC (EFTRW)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-09-07
5:12 pm
Purchase
2021-08-25 13D eFFECTOR Therapeutics, Inc.
EFTR
The Column Group II, LP 172,373
10.600%
172,373increase
(New Position)
Filing
History
2021-09-03
4:00 pm
Purchase
2021-08-25 13D eFFECTOR Therapeutics, Inc.
EFTR
Abingworth LLP 192,885
11.900%
192,885increase
(New Position)
Filing
History
2021-08-25
2:07 pm
Sale
2021-08-24 13G Locust Walk Acquisition Corp.
LWAC
Feis Lawrence 0
0.000%
-906,661decrease
(Position Closed)
Filing
History
2021-08-20
4:09 pm
Purchase
2021-08-10 13G Locust Walk Acquisition Corp.
LWAC
Beryl Capital Management LLC 1,261,330
7.000%
1,261,330increase
(New Position)
Filing
History
2021-08-17
11:24 am
Purchase
2021-08-16 13G Locust Walk Acquisition Corp.
LWAC
Feis Lawrence 906,661
5.020%
906,661increase
(New Position)
Filing
History
2021-02-05
9:28 pm
Purchase
2021-02-01 13G LOCUST WALK ACQ CORP UNIT 1 CL
LWACU
Linden Capital L.P. 928,094
5.100%
928,094increase
(New Position)
Filing
History
2021-01-21
09:01 am
Purchase
2021-01-12 13G LOCUST WALK ACQ CORP UNIT 1 CL
LWACU
Empyrean Capital Partners, LP 1,000,000
5.500%
1,000,000increase
(New Position)
Filing
History
Goto Prev, 0, 1